Use of prophylactic antibiotics for intra-vesicle Botox® injection
| Autor: | Naeem Shaikh, Philip Koenig, Mohammad Hassan Khan, Omer Baldo |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Male
medicine.medical_specialty medicine.drug_class Urology Antibiotics Acetylcholine Release Inhibitors 030232 urology & nephrology urologic and male genital diseases 03 medical and health sciences 0302 clinical medicine Ciprofloxacin medicine Humans In patient Botulinum Toxins Type A Urinary Bladder Neurogenic Antibiotic prophylaxis Retrospective Studies 030219 obstetrics & reproductive medicine Urinary bladder Urinary Bladder Overactive business.industry Incidence (epidemiology) Retrospective cohort study Antibiotic Prophylaxis Middle Aged female genital diseases and pregnancy complications Anti-Bacterial Agents Surgery Administration Intravesical Treatment Outcome medicine.anatomical_structure Female Case note Neurology (clinical) Hyperactive bladder business |
| Zdroj: | Neurourology and Urodynamics. 36:828-828 |
| ISSN: | 0733-2467 |
| DOI: | 10.1002/nau.23034 |
| Popis: | Aim Botox injection in bladder wall is increasingly used in urology for over active bladder and neurogenic bladder. Aim of this audit is to assess the incidence of UTI after procedure and need for routine use of pre and post procedure antibiotics. Method It was case notes and lab results based retrospective study of all the patients attended for intra-vesicle Botox injection. Results Rate of UTI's were lower in the group who received antibiotics pre and post operatively as compared to those who did not. Conclusion Routine antibiotics use lowers the risk of UTI's in patients receiving intra-vesicle botox. Neurourol. Urodynam. © 2016 Wiley Periodicals, Inc. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text